RENAL CELL CARCINOMA STAGE I

This adverse event was reported 87 times

RENAL CELL CARCINOMA STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAPINAROF 1 0.0005
1 THIOTEPA 4 0.0004
2 BARICITINIB 1 0.0003
3 SIROLIMUS 3 0.0002
4 ACITRETIN 1 0.0002
5 CLINDAMYCIN PHOSPHATE 1 0.0002
6 CLONIDINE HYDROCHLORIDE 1 0.0002
7 TAPENTADOL HYDROCHLORIDE 5 0.0001
8 TEMOZOLOMIDE 3 0.0001
9 MYCOPHENILIC ACID 3 0.0001
See all drugs enriched for association with RENAL CELL CARCINOMA STAGE I